Technical Analysis for PAND - Pandion Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Extremely Strong | N/A | Up | Flat |
| Historical PAND trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 134.30% | |
| Boomer Buy Setup | Bullish Swing Setup | 134.30% | |
| Calm After Storm | Range Contraction | 134.30% | |
| NR7 | Range Contraction | 134.30% | |
| Upper Bollinger Band Walk | Strength | 134.30% | |
| Inside Day | Range Contraction | 134.30% | |
| Wide Bands | Range Expansion | 134.30% | |
| Overbought Stochastic | Strength | 134.30% | |
| Upper Bollinger Band Touch | Strength | 134.30% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | 139.15% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Pandion Therapeutics is developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. Pandion’s TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform enables the company to create a pipeline of product candidates using immunomodulatory effector modules, with the ability to also combine an effector module with a tissue-targeted tether module in a bifunctional format. Pandion’s lead product candidate, PT101, is currently in a Phase 1a clinical trial.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Autoimmune Disease Autoimmunity Drug Design
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Immunotherapy Autoimmune Diseases Autoimmune Disease Autoimmunity Drug Design
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 62.8 |
| 52 Week Low | 10.28 |
| Average Volume | 394,440 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 40.02 |
| 20-Day Moving Average | 60.07 |
| 10-Day Moving Average | 60.02 |
| Average True Range | 1.09 |
| ADX | 85.35 |
| +DI | 52.91 |
| -DI | 2.84 |
| Chandelier Exit (Long, 3 ATRs ) | 59.54 |
| Chandelier Exit (Short, 3 ATRs ) | 62.86 |
| Upper Bollinger Band | 60.74 |
| Lower Bollinger Band | 59.40 |
| Percent B (%b) | 0.48 |
| BandWidth | 2.24 |
| MACD Line | 5.13 |
| MACD Signal Line | 6.62 |
| MACD Histogram | -1.4895 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 60.20 | ||||
| Resistance 3 (R3) | 60.18 | 60.12 | 60.18 | ||
| Resistance 2 (R2) | 60.12 | 60.08 | 60.13 | 60.17 | |
| Resistance 1 (R1) | 60.08 | 60.05 | 60.10 | 60.10 | 60.16 |
| Pivot Point | 60.02 | 60.02 | 60.03 | 60.03 | 60.02 |
| Support 1 (S1) | 59.98 | 59.98 | 60.00 | 60.00 | 59.94 |
| Support 2 (S2) | 59.92 | 59.95 | 59.93 | 59.93 | |
| Support 3 (S3) | 59.88 | 59.92 | 59.93 | ||
| Support 4 (S4) | 59.90 |
